Mistry PK - Search Results

1

Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.

Mistry PK, Sadan S, Yang R, Yee J, Yang M. Mistry PK, et al. Am J Hematol. 2007 Aug;82(8):697-701. doi: 10.1002/ajh.20908. Am J Hematol. 2007. PMID: 17492645 Free article.

2

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.

Weinreb NJ, Barranger JA, Charrow J, Grabowski GA, Mankin HJ, Mistry P. Weinreb NJ, et al. Am J Hematol. 2005 Nov;80(3):223-9. doi: 10.1002/ajh.20504. Am J Hematol. 2005. PMID: 16247743 Free article. Review.

3

Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.

El-Beshlawy A, Ragab L, Youssry I, Yakout K, El-Kiki H, Eid K, Mansour IM, Abd El-Hamid S, Yang M, Mistry PK. El-Beshlawy A, et al. Among authors: mistry pk. J Inherit Metab Dis. 2006 Feb;29(1):92-8. doi: 10.1007/s10545-006-0121-6. J Inherit Metab Dis. 2006. PMID: 16601874

4

Phenotype variations in Gaucher disease.

Mistry P, Germain DP. Mistry P, et al. Rev Med Interne. 2006 Mar;27 Suppl 1:S3-10. doi: 10.1016/s0248-8663(06)80002-0. Rev Med Interne. 2006. PMID: 16644399 English, French.

5

Therapeutic goals in Gaucher disease.

Mistry P, Germain DP. Mistry P, et al. Rev Med Interne. 2006 Mar;27 Suppl 1:S30-8. doi: 10.1016/s0248-8663(06)80009-3. Rev Med Interne. 2006. PMID: 16644400 English, French.

6

Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Cox TM, Aerts JM, Belmatoug N, Cappellini MD, vom Dahl S, Goldblatt J, Grabowski GA, Hollak CE, Hwu P, Maas M, Martins AM, Mistry PK, Pastores GM, Tylki-Szymanska A, Yee J, Weinreb N. Cox TM, et al. Among authors: mistry pk. J Inherit Metab Dis. 2008 Jun;31(3):319-36. doi: 10.1007/s10545-008-0779-z. Epub 2008 May 23. J Inherit Metab Dis. 2008. PMID: 18509745 Review.

7

Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease.

DeMayo RF, Haims AH, McRae MC, Yang R, Mistry PK. DeMayo RF, et al. Among authors: mistry pk. AJR Am J Roentgenol. 2008 Jul;191(1):115-23. doi: 10.2214/AJR.07.3550. AJR Am J Roentgenol. 2008. PMID: 18562733 Free PMC article.

8

Life expectancy in Gaucher disease type 1.

Weinreb NJ, Deegan P, Kacena KA, Mistry P, Pastores GM, Velentgas P, vom Dahl S. Weinreb NJ, et al. Am J Hematol. 2008 Dec;83(12):896-900. doi: 10.1002/ajh.21305. Am J Hematol. 2008. PMID: 18980271 Free PMC article.

9

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.

Taddei TH, Kacena KA, Yang M, Yang R, Malhotra A, Boxer M, Aleck KA, Rennert G, Pastores GM, Mistry PK. Taddei TH, et al. Among authors: mistry pk. Am J Hematol. 2009 Apr;84(4):208-14. doi: 10.1002/ajh.21362. Am J Hematol. 2009. PMID: 19260119 Free PMC article.

10

Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

Grabowski GA, Kacena K, Cole JA, Hollak CE, Zhang L, Yee J, Mistry PK, Zimran A, Charrow J, vom Dahl S. Grabowski GA, et al. Among authors: mistry pk. Genet Med. 2009 Feb;11(2):92-100. doi: 10.1097/GIM.0b013e31818e2c19. Genet Med. 2009. PMID: 19265748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters